The existence of multiple conformers of interleukin-21 directs engineering of a superpotent analogue

被引:28
作者
Bondensgaard, Kent
Breinholt, Jens
Madsen, Dennis
Omkvist, Diana Hojmark
Kang, Lishan
Worsaae, Anne
Becker, Peter
Schiodt, Christine Bruun
Hjorth, Siv A.
机构
[1] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark
[2] Novo Nordisk R&D, Beijing 10228, Peoples R China
关键词
D O I
10.1074/jbc.M701313200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The high resolution three-dimensional structure of human interleukin (hIL)-21 has been resolved by heteronuclear NMR spectroscopy. Overall, the hIL-21 structure is dominated by a well defined central four-helical bundle, arranged in an up-up-down-down topology, as observed for other cytokines. A segment of the hIL-21 molecule that includes the third helical segment, helix C, is observed to exist in two distinct and interchangeable states. In one conformer, the helix C segment is presented in a regular, alpha-helical conformation, whereas in the other conformer, this segment is largely disordered. A structure-based sequence alignment of hIL-21 with receptor complexes of the related cytokines, interleukin-2 and -4, implied that this particular segment is involved in receptor binding. An hIL-21 analog was designed to stabilize the region around helix C through the introduction of a segment grafted from hIL-4. This novel hIL-21 analog was demonstrated to exhibit a 10-fold increase in potency in a cellular assay.
引用
收藏
页码:23326 / 23336
页数:11
相关论文
共 33 条